Literature DB >> 8926288

Altered synthesis of interferon-gamma and expression of interferon-gamma receptor by peripheral blood mononuclear cells from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis.

N Yano1, M Endoh, R Naka, F Takemura, Y Nomoto, H Sakai.   

Abstract

Previously we reported disease-specific interaction between interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) in patients with IgA nephropathy (IgAN), suggesting the existence of unusual T cell behavior in this disease. In the present study, we investigated characteristic synthesis of interferon-gamma (IFN-gamma) and expression of IFN-gamma receptor (IFN-gamma R) in the peripheral blood mononuclear cells (PBMC) from patients with IgAN and other chronic proliferative glomerulonephritis (PGN). Heparinized peripheral blood samples were obtained from 38 patients with chronic mesangial proliferative glomerulonephritis (CGN; including 24 with IgA nephropathy) and 20 healthy controls. PBMC were isolated by gradient centrifugation and fragments were cultured in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% fetal calf serum (FCS) for 72 hr. IFN-gamma concentrations in supernatants were evaluated by the enzyme-linked immunosorbent assay (ELISA). Other parts of PBMC pellets were reacted with anti-human IFN-gamma R monoclonal antibody and FITC-labeled anti-mouse second antibody for analysis of IFN-gamma R expression on these cells by FACScan. The remaining PBMC were fractionated into CD4+ T cells, CD8+ T cells, B cells, NK, cells and macrophages using the MACS cell sorting system. The isolated cells were evaluated for IFN-gamma or IFN-gamma R mRNA expression by the semiquantitative RT-PCR method. In vitro IFN-gamma synthesis was enhanced in patients with CGN, and NK cells were revealed to be responsible for such enhancement. On the other hand, the expression of IFN-gamma R on macrophages was suppressed in CGN patients. These results suggest that impairment of regulation of the IFN-gamma system might be involved in the development of CGN.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926288     DOI: 10.1007/bf01540975

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Thromboxane A2, prostaglandins, and mesangial cell proliferation.

Authors:  P Menè; F Pugliese; A D'Agostino; G A Cinotti
Journal:  Kidney Int       Date:  1992-03       Impact factor: 10.612

2.  Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy.

Authors:  N Yano; M Endoh; M Miyazaki; F Yamauchi; Y Nomoto; H Sakai
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Significance of mononuclear phagocytes in IgA nephropathy.

Authors:  S Arima; M Nakayama; M Naito; T Sato; K Takahashi
Journal:  Kidney Int       Date:  1991-04       Impact factor: 10.612

4.  Interstitial naive and memory T cells in chronic mesangial proliferative glomerulonephritis.

Authors:  N Yano; M Endoh; A Kashem; M Miyazaki; Y Nomoto; H Sakai
Journal:  Nephron       Date:  1993       Impact factor: 2.847

5.  T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.

Authors:  K N Lai; J C Leung; F M Lai; J S Tam
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

6.  Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis.

Authors:  L Gesualdo; M Pinzani; J J Floriano; M O Hassan; N U Nagy; F P Schena; S N Emancipator; H E Abboud
Journal:  Lab Invest       Date:  1991-08       Impact factor: 5.662

7.  Early gamma interferon production by natural killer cells is important in defense against murine listeriosis.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.

Authors:  M Gómez-Chiarri; A Ortíz; J L Lerma; M J López-Armada; F Mampaso; E González; J Egido
Journal:  Lab Invest       Date:  1994-04       Impact factor: 5.662

9.  Down-regulation of peripheral blood cell interferon receptors in chronic myelogenous leukemia patients undergoing human interferon (HuIFN alpha) therapy.

Authors:  B L Maxwell; M Talpaz; J U Gutterman
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

10.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  3 in total

1.  Phenotypic characterization of cytokine expression in patients with IgA nephropathy.

Authors:  N Yano; M Endoh; Y Nomoto; H Sakai; K Fadden; A Rifai
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection.

Authors:  J Shibata; H Goto; T Arisawa; Y Niwa; T Hayakawa; A Nakayama; N Mori
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  Th1 Cytokines Signature in 2 Cases of IgA Nephropathy Flare after mRNA-Based SARS-CoV-2 Vaccine: Exploring the Pathophysiology.

Authors:  Laura Martinez Valenzuela; Laia Oliveras; Montserrat Gomà; Eugenia Quiros; Paula Antón-Pámpols; Francisco Gómez-Preciado; Xavier Fulladosa; Josep Maria Cruzado; Juan Torras; Juliana Draibe
Journal:  Nephron       Date:  2022-05-31       Impact factor: 3.457

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.